Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03758976 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. 3 versions Re-verified since Feb 27, 2020, no change to tracked fieldsv5-v7
  2. Site details revised at 1 of 2 sitesv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Jan 2, 2019 to Jan 21, 2019
    v3
  4. Start date: Dec 3, 2018 to Jan 2, 2019v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective multicenter observational study to assess molecular drivers of metastatic breast cancer and disease evolution upon therapeutic pressure. The main aim is to develop and validate prognostic, predictive and pathogenic markers in clinically well-characterized population-based material of breast cancer tumors and the corresponding normal tissue.These data will be used to characterize recurrent breast cancer on a molecular level, study tumor evolution, develop biomarkers of response/resistance to targeted therapy in the metastatic setting, enroll patients on targeted treatment clinical studies and to elucidate mechanisms of resistance to therapy.
Trial Details
NCT Number NCT03758976
Lead Sponsor Lund University Hospital
Conditions
(from sponsor)		 Metastatic Breast Cancer
Related terms Breast Neoplasms, Neoplastic Cells, Circulating
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov